Literature DB >> 15925588

Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation.

Carl A Gregory1, Darwin J Prockop, Jeffrey L Spees.   

Abstract

The first non-hematopoietic mesenchymal stem cells (MSCs) were discovered by Friedenstein in 1976, who described clonal, plastic adherent cells from bone marrow capable of differentiating into osteoblasts, adipocytes, and chondrocytes. More recently, investigators have now demonstrated that multi-potent MSCs can be recovered from a variety of other adult tissues and differentiate into numerous tissue lineages including myoblasts, hepatocytes and possibly even neural tissue. Because MSCs are multipotent and easily expanded in culture, there has been much interest in their clinical potential for tissue repair and gene therapy and as a result, numerous studies have been carried out demonstrating the migration and multi-organ engraftment potential of MSCs in animal models and in human clinical trials. This review describes the recent advances in the understanding of MSC biology.

Entities:  

Mesh:

Year:  2005        PMID: 15925588     DOI: 10.1016/j.yexcr.2005.03.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  86 in total

1.  Biphasic peptide amphiphile nanomatrix embedded with hydroxyapatite nanoparticles for stimulated osteoinductive response.

Authors:  Joel M Anderson; Jessica L Patterson; Jeremy B Vines; Amjad Javed; Shawn R Gilbert; Ho-Wook Jun
Journal:  ACS Nano       Date:  2011-11-17       Impact factor: 15.881

2.  Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype.

Authors:  Trimble L B Spitzer; Angela Rojas; Zara Zelenko; Lusine Aghajanova; David W Erikson; Fatima Barragan; Michelle Meyer; John S Tamaresis; Amy E Hamilton; Juan C Irwin; Linda C Giudice
Journal:  Biol Reprod       Date:  2012-02-29       Impact factor: 4.285

3.  The isolation and characterization of putative mesenchymal stem cells from the spiny mouse.

Authors:  Hayley Dickinson; Phillipa Milton; Graham Jenkin
Journal:  Cytotechnology       Date:  2012-02-26       Impact factor: 2.058

Review 4.  Stem cell transplantation in multiple sclerosis: current status and future prospects.

Authors:  Gianvito Martino; Robin J M Franklin; Anne Baron Van Evercooren; Douglas A Kerr
Journal:  Nat Rev Neurol       Date:  2010-04-20       Impact factor: 42.937

Review 5.  Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches.

Authors:  Makio Ogawa; Amanda C Larue; Patricia M Watson; Dennis K Watson
Journal:  Int J Hematol       Date:  2010-03-26       Impact factor: 2.490

6.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.

Authors:  Jessica L Lo Surdo; Bryan A Millis; Steven R Bauer
Journal:  Cytotherapy       Date:  2013-08-29       Impact factor: 5.414

7.  An ultrastructural and immunohistochemical study of a combined submucosal granular cell tumor and lipoma of the colon showing a unique nodule-in-nodule structure: putative implication of CD34 or prominin-2-positive stromal cells in its histopathogenesis.

Authors:  Taisuke Mori; Hideki Orikasa; Takeharu Shigematsu; Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2006-05-04       Impact factor: 4.064

8.  Mesenchymal stem cells and tissue engineering.

Authors:  Nicholas W Marion; Jeremy J Mao
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 9.  Craniofacial tissue engineering by stem cells.

Authors:  J J Mao; W V Giannobile; J A Helms; S J Hollister; P H Krebsbach; M T Longaker; S Shi
Journal:  J Dent Res       Date:  2006-11       Impact factor: 6.116

Review 10.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.